HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19. - Astbury S; Reynolds CJ; Butler DK; Muñoz-Sandoval DC; Lin KM; Pieper FP; Otter A; Kouraki A; Cusin L; Nightingale J; Vijay A; Craxford S; et al. (Immunology, 2022)